Literature DB >> 20405159

Spanish recommendations on economic evaluation of health technologies.

Julio López-Bastida1, Juan Oliva, Fernando Antoñanzas, Anna García-Altés, Ramón Gisbert, Javier Mar, Jaume Puig-Junoy.   

Abstract

The economic evaluation of health technologies has become a major tool in health policy in Europe for prioritizing the allocation of health resources and the approval of new technologies. The objective of this proposal was to develop guidelines for the economic evaluation of health technologies in Spain. A group of researchers specialized in economic evaluation of health technologies developed the document reported here, following the initiative of other countries in this framework, to provide recommendations for the standardization of methodology applicable to economic evaluation of health technologies in Spain. Recommendations appear under 17 headings or sections. In each case, the recommended requirements to be satisfied by economic evaluation of health technologies are provided. Each recommendation is followed by a commentary providing justification and compares and contrasts the proposals with other available alternatives. The economic evaluation of health technologies should have a role in assessing health technologies, providing useful information for decision making regarding their adoption, and they should be transparent and based on scientific evidence.

Mesh:

Year:  2010        PMID: 20405159     DOI: 10.1007/s10198-010-0244-4

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  77 in total

Review 1.  Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries.

Authors:  Emelie Heintz; Andreas Gerber-Grote; Salah Ghabri; Francoise F Hamers; Valentina Prevolnik Rupel; Renata Slabe-Erker; Thomas Davidson
Journal:  Pharmacoeconomics       Date:  2016-01       Impact factor: 4.981

2.  Methodological reviews of economic evaluations in health care: what do they target?

Authors:  Maria-Florencia Hutter; Roberto Rodríguez-Ibeas; Fernando Antonanzas
Journal:  Eur J Health Econ       Date:  2013-08-24

3.  Cost-Effectiveness of Fixed-Dose Combinations Therapies for Chronic Obstructive Pulmonary Disease Treatment.

Authors:  Margarita Capel; María Mareque; Carlos José Álvarez; Leandro Lindner; Itziar Oyagüez
Journal:  Clin Drug Investig       Date:  2018-07       Impact factor: 2.859

Review 4.  The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications.

Authors:  José Manuel Rodríguez Barrios; Ferran Pérez Alcántara; Carlos Crespo Palomo; Paloma González García; Enrique Antón De Las Heras; Max Brosa Riestra
Journal:  Eur J Health Econ       Date:  2011-06-10

5.  Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.

Authors:  Mónica Hernández Alava; Allan Wailoo; Stephen Pudney; Laura Gray; Andrea Manca
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

6.  Korean guidelines for pharmacoeconomic evaluation (second and updated version) : consensus and compromise.

Authors:  Seungjin Bae; Soook Lee; Eun Young Bae; Sunmee Jang
Journal:  Pharmacoeconomics       Date:  2013-04       Impact factor: 4.981

7.  The cost associated with interstitial thermotherapy for tonsil reduction vs. standard tonsillectomy.

Authors:  Francisco Larrosa; Maria J Dura; Joan Jeremias; Miquel Guirao; Anna Alberti; Enrique Romero
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-22       Impact factor: 2.503

8.  Robotic versus laparoscopic surgery for rectal cancer: a comparative cost-effectiveness study.

Authors:  Y Quijano; J Nuñez-Alfonsel; B Ielpo; V Ferri; R Caruso; H Durán; E Díaz; L Malavé; I Fabra; E Pinna; R Isernia; Á Hidalgo; E Vicente
Journal:  Tech Coloproctol       Date:  2020-02-04       Impact factor: 3.781

9.  The economic burden of metastatic breast cancer in Spain.

Authors:  Begoña Bermejo de Las Heras; Javier Cortes Ramon Y Cajal; Elena Galve Calvo; Juan de la Haba Rodriguez; Jesus Garcia Mata; Fernando Moreno Anton; Ignacio Pelaez Fernandez; Alvaro Rodriguez-Lescure; Cesar A Rodriguez Sanchez; Manuel Ruiz-Borrego; Edit Remak; Magdolna Barra; Maria Rivero; Javier Soto Alvarez
Journal:  Eur J Hosp Pharm       Date:  2018-07-30

10.  Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Santiago Grau; Rafael Cámara; Manuel Jurado; Jaime Sanz; Belén Aragón; Irmina Gozalbo
Journal:  Eur J Health Econ       Date:  2017-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.